Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (109)

View All

Latest Posts

About This Stock More About This Stock
Bristol-Myers: "Boring Is Good"
Article By: MoneyShow.com
Monday, May 9, 2022 9:54 AM EDT
The firm’s big money-making drug, Revlimid (acquired when it bought Celgene a few years back), which treats a cancer of plasma cells called multiple myeloma, is facing increasing generic competition.
In this article: BMY
Read
Bristol-Myers To Post Q1 Earnings: Is A Beat In Store?
Article By: Zacks Investment Research
Thursday, April 28, 2022 12:20 AM EDT
Bristol-Myers Squibb Company is scheduled to report first-quarter 2022 results on Apr 29, before market open.
In this article: BMY
Read
Bristol-Myers Squibb: A Drip For Long-Term Returns
Article By: MoneyShow.com
Sunday, April 24, 2022 12:44 PM EDT
One of the more frustrating stocks I have owned is Bristol-Myers Squibb. Indeed, the company is an original member of my portfolio when my newsletter was first published 30 years ago. Is it a good investment for the long-term despite the frustration?
In this article: BMY
Read
Healthy Pharma Favorites
Article By: MoneyShow.com
Friday, March 25, 2022 11:02 AM EDT
Here's a look at two drug makers that we recommend in our Growth & Income Portfolio. The stocks in this portfolio are generally higher-quality, larger-cap companies that have fallen out of favor.
In this article: BMY, MRK, OGN
Read
Top 3 Undervalued Dividend Growth Stocks In 2022
Article By: Dividend Power
Thursday, March 17, 2022 7:16 AM EDT
In turbulent times like what we are experiencing right now, blue-chip stocks that pay rising dividends can be a good choice.
In this article: BMY, WSM, EXPD
Read
All Posts

Latest Tweets for $BMY

No tweets yet!

PARTNER HEADLINES

$BMY

Comments Status Updates
Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber • 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

Bristol-Meyers (BMY) Head And Shoulders Pattern
Flat Broke • 2/26/2020 8:46:50 PM

I fear bad news is acoming for $BMY.

Bristol-Myers To Buy Celgene; A $74 Billion Deal
Kalara J. Curtis • 5/22/2019 10:47:49 AM

Nice info, thanks for sharing with us. Bullish on $BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan • 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 4 of 4 comments